AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • September 10th, 2014 • Silenseed Ltd. • Pharmaceutical preparations
Contract Type FiledSeptember 10th, 2014 Company IndustryThis amendment (the “Amendment”) to the Agreement dated February 23, 2009 (the “Agreement”) is entered into by and between Hadasit Medical Research Services and Development Limited, (hereinafter: “Institution”), Prof. Eithan Galun (the “Consultant”), and Silenseed Ltd., a corporation organized under the laws of Israel, with its registered office located at the Goldyne Savad Institute of Gene Therapy, Hadassah Medical Center, Jerusalem 91120 Israel (hereinafter: “Company”) is made and effective as of March 12, 2012.
CONSULTING AGREEMENTConsulting Agreement • September 10th, 2014 • Silenseed Ltd. • Pharmaceutical preparations
Contract Type FiledSeptember 10th, 2014 Company IndustryThis Agreement is entered into as of February 23, 2009 with full force and effect as of June 10, 2008 (the "Effective Date") by and between HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LIMITED, a company duly incorporated under the laws of Israel, of P.O. Box 12000, Jerusalem 91120, (hereinafter: "Hadasit"), Prof Eithan Galun (the "Consultant"), and SILENSEED Ltd., a corporation organized under the laws of Israel, with its registered office located at the Goldyne Savad Institute of Gene Therapy, Hadassah Medical Center, Jerusalem 91120 Israel (hereinafter: "Company").